Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient | Zendy

Robustelli Test Elisa | Zendy; Fumo Giuseppe | Zendy; Corbeddu Marialuisa | Zendy; Ferreli Caterina | Zendy; Rongioletti Franco | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient

Author(s) -

Robustelli Test Elisa,

Fumo Giuseppe,

Corbeddu Marialuisa,

Ferreli Caterina,

Rongioletti Franco

Publication year - 2020

Publication title -

dermatologic therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.595

H-Index - 68

eISSN - 1529-8019

pISSN - 1396-0296

DOI - 10.1111/dth.13263

Subject(s) - medicine , imiquimod , bowen's disease , dermatology , basal cell , disease , cheek , carcinoma in situ , carcinoma , surgery

Bowen's disease is a cutaneous squamous cell carcinoma (SCC) in situ with a potential risk of progression to invasive SCC. Despite the high number of approved treatments, elderly patients with extensive lesions of critical sites may represent a therapeutical challenge, especially in cases of treatment failure or recalcitrant disease. Here, we report the successfully use of topical Imiquimod 3.75% to treat an extensive Bowen's disease of the cheek in an elderly.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research